ICUI stock: buy or sell?

ICUI stock price: $166.41 0.89% At close on August 22nd, 2019

Updated on:
August 22nd, 2019


ICU Medical gained a slightly good 0.89% and closed at $166.41.

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide.

Should I buy ICUI stock?

Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. That's why is so important to define your own trading strategy that matches with your character as inversor. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with ICU Medical stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean ICUI will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is ICU Medical stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. At, we collected 3 ratings published for ICUI stock in the last month.

Is ICUI a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-8Raymond JamesStrong-BuyOutperform
2019-3-1Raymond JamesStrong-BuyBuy
2019-3-1Raymond JamesStrong-BuyStrong-Buy

ICUI stock analysis

Daily outlook

ICU Medical closed yesterday at $166.41 and gained a slightly good 0.89%.

ICU Medical shares gained 0.89% to $166.41 yesterday. Since August 8th when ICUI stock price broke down the SMA200d line, it slid $-79.26 per share (-32.26%). Since SMA50d and SMA100d crossed up on July 12th, ICUI price slid a -32.51%.

ICUI stock chart (daily)

Weekly outlook

ICU Medical stayed stable a tight 0.25% this week. Early August ICUI collapsed a chilling -53.36% in just one week.

Since early August, when ICUI stock price broke down the 40-weeks moving avarage line, it slid $-89.54 per share (-34.98%). Trading stocks that are under the 40-weeks (that is, 200-days) moving average line is not recommended by many experts, as it indicates that the stock has not enough institutional support.

ICUI stock chart (weekly)

ICUI stock price history

ICUI stock went public on March 31st, 1992 with a price of $5.331. Since then, ICUI stock surged a 3,022.10%, with an average of 111.90% per year. If you had invested right after ICUI's IPO a $1,000 in ICUI stock in 1992, it would worth $30,221.00 today.

1: Adjusted price after possible price splits or reverse-splits.

ICUI stock historical price chart

ICUI stock reached 52-week highs on September at $312.45, and all-time highs 2018-08-10 with a price of 321.7.

ICUI stock price target is $300.00

Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We found 2 price predictions for ICUI stock published in the last month:
ICUI stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-3-1Raymond JamesReiterates$315.00$300.00-4.8%
2019-3-1Raymond JamesLowers Target$315.00$300.00-4.8%
(in average)$315.00$300.00-5.0%
Moving in a range from $300.00 and $300.00, the price target for ICU Medical stock is $300.00. In average, analysts' outlook on ICUI price forecast is negative, downsizing the target by a -5.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

ICU Medical presented more than good results for 2018-Q4 on February. ICU Medical soared Earnings per Share (EPS) by 14.10%, beating experts estimates of $1.56. ICU Medical posted $1.78.
ICUI earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

Compared to 2017, last anual revenues report draw a more than good increase of 8.31% to $1,400.04 million dollars. However, its income margin (compared to sales) declined to 2.06%, that is $28.79 million.

ICUI annual Sales and Income evolution
2013$314 M-$40 M12.9%-
2014$309 M-1.42%$26 M8.5%-34.85%
2015$342 M10.48%$45 M13.2%70.82%
2016$379 M11.04%$63 M16.6%40.23%
2017$1,293 M240.72%$69 M5.3%8.81%
2018$1,400 M8.31%$29 M2.1%-58.05%

Quarterly financial results

ICU Medical posted $340.38 M in revenues for 2018-Q4, a 4.04% improvement compared to previous quarter. Reported quarter earnings marked $-7.36 million with a profit margin of -2.16%. Profit margin depreciated a -2.23% compared to previous quarter when profit margin was 0.07%. When comparing revenues to same quarter last year, ICU Medical sales marked a terrifying correction and dropped a -8.04%.
ICUI quarterly Sales and Income evolution
2017-Q1$248 M-$56 M22.5%-
2017-Q2$332 M33.81%$-37 M-11.2%-166.34%
2017-Q3$343 M3.54%$0 M0.0%-100.37%
2017-Q4$370 M7.83%$50 M13.4%36,447.79%
2018-Q1$372 M0.52%$5 M1.3%-90.19%
2018-Q2$360 M-3.11%$31 M8.6%537.01%
2018-Q3$327 M-9.24%$0 M0.1%-99.29%
2018-Q4$340 M4.04%$-7 M-2.2%-3,458.45%

ICU Medical ownership

When you are planning to buy shares of a company, it's always worth to review its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For ICU Medical, 7.13% of all outstanding shares are owned by its staff.

Bearish positions for ICUI stock account 0.00%, no big difference from last month.

For a better context understanding, the next table shows ownership data compared to other related companies:

Market cap$3.4 B$696.4 M$44.5 B$68.8 B$45.1 B
Total shares20.6 M37.3 M510.2 M269.7 M208.1 M
Float shares19.2 M36.8 M509.5 M269.1 M206.6 M
  - Institutional holdings (%)93.5%102.5%88.2%87.5%0.0%
  - Insider holdings (%)7.1%2.5%0.1%0.3%3.9%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

ICUI summary

Thursday, August 22nd, 2019
Day range$163.96 - $167.98
Previous close$164.94
Session gain0.89%
Average true range$11.46
50d mov avg$230.70
100d mov avg$229.53
200d mov avg$233.51
Daily patternlb11a
Weekly pattern

ICU Medical performance

To better understand ICU Medical performance you must becnhmark its gains with other related stocks in same sector or industry. For ICU Medical, the benchmark is made against AngioDynamics, Baxter International, Becton, Dickinson and, Edwards Lifesciences, Merit Medical Systems, Insulet and Teleflex.
ICUIICU Medical-26.26%-33.43%-45.26%
BAXBaxter Internatio...16.45%17.41%21.84%
BDXBecton, Dickinson...8.85%2.86%1.17%
EWEdwards Lifescien...27.92%25.60%52.88%
MMSIMerit Medical Sys...-34.33%-41.88%-39.91%

ICU Medical competitors

One check before trading any stock is to review a list of its competitors, in this case for ICU Medical. We selected 7 companies as ICU Medical competitors as they are in the same industry or have similar market objectives.